Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.

Bergman P, Piket E, Khademi M, James T, Brundin L, Olsson T, Piehl F, Jagodic M.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e219. doi: 10.1212/NXI.0000000000000219. eCollection 2016 Jun.

2.

pH-Controlled assembly of two novel Dawson-sandwiched clusters involving the in situ reorganization of trivacant α-[P2W15O56](12-) into divacant α-[P2W16O57](8.).

Guo LY, Jagodič M, Zeng SY, Wang Z, Shi ZQ, Wang XP, Tung CH, Sun D.

Dalton Trans. 2016 May 28;45(20):8404-11. doi: 10.1039/c6dt00793g. Epub 2016 Apr 25.

PMID:
27108482
3.

Translational utility of experimental autoimmune encephalomyelitis: recent developments.

Guerreiro-Cacais AO, Laaksonen H, Flytzani S, N'diaye M, Olsson T, Jagodic M.

J Inflamm Res. 2015 Nov 13;8:211-25. doi: 10.2147/JIR.S76707. eCollection 2015. Review.

4.

Rat bone marrow-derived dendritic cells generated with GM-CSF/IL-4 or FLT3L exhibit distinct phenotypical and functional characteristics.

N'diaye M, Warnecke A, Flytzani S, Abdelmagid N, Ruhrmann S, Olsson T, Jagodic M, Harris RA, Guerreiro-Cacais AO.

J Leukoc Biol. 2016 Mar;99(3):437-46. doi: 10.1189/jlb.1AB0914-433RR. Epub 2015 Oct 29.

PMID:
26516183
5.

MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated.

Flytzani S, Guerreiro-Cacais AO, N'diaye M, Lindner M, Linington C, Meinl E, Stridh P, Jagodic M, Olsson T.

J Neuroinflammation. 2015 Oct 29;12:194. doi: 10.1186/s12974-015-0417-2.

6.

Silencing the α2 subunit of γ-aminobutyric acid type A receptors in rat dorsal root ganglia reveals its major role in antinociception posttraumatic nerve injury.

Obradovic AL, Scarpa J, Osuru HP, Weaver JL, Park JY, Pathirathna S, Peterkin A, Lim Y, Jagodic MM, Todorovic SM, Jevtovic-Todorovic V.

Anesthesiology. 2015 Sep;123(3):654-67. doi: 10.1097/ALN.0000000000000767.

PMID:
26164299
7.

MicroRNAs as promising novel biomarkers and potential drug targets for inflammatory neurological diseases.

Piehl F, Jagodic M.

J Neurol Sci. 2015 Sep 15;356(1-2):3-4. doi: 10.1016/j.jns.2015.06.023. Epub 2015 Jun 14. No abstract available.

PMID:
26099168
8.

Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?

Ruhrmann S, Stridh P, Kular L, Jagodic M.

Int J Biochem Cell Biol. 2015 Oct;67:49-57. doi: 10.1016/j.biocel.2015.05.010. Epub 2015 May 19. Review.

PMID:
26002250
9.

Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.

Castelo-Branco G, Stridh P, Guerreiro-Cacais AO, Adzemovic MZ, Falcão AM, Marta M, Berglund R, Gillett A, Hamza KH, Lassmann H, Hermanson O, Jagodic M.

Neurobiol Dis. 2014 Nov;71:220-33. doi: 10.1016/j.nbd.2014.08.019. Epub 2014 Aug 19.

10.

Positional Gene Cloning in Experimental Populations.

Jagodic M, Stridh P.

Methods Mol Biol. 2016;1304:3-24. doi: 10.1007/7651_2014_108.

PMID:
25103675
11.

The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.

Laaksonen H, Guerreiro-Cacais AO, Adzemovic MZ, Parsa R, Zeitelhofer M, Jagodic M, Olsson T.

Genes Immun. 2014 Oct;15(7):457-65. doi: 10.1038/gene.2014.36. Epub 2014 Jul 10.

PMID:
25008863
12.

Identification of candidate risk gene variations by whole-genome sequence analysis of four rat strains commonly used in inflammation research.

Bäckdahl L, Ekman D, Jagodic M, Olsson T, Holmdahl R.

BMC Genomics. 2014 May 21;15:391. doi: 10.1186/1471-2164-15-391.

13.

Parent-of-origin effects implicate epigenetic regulation of experimental autoimmune encephalomyelitis and identify imprinted Dlk1 as a novel risk gene.

Stridh P, Ruhrmann S, Bergman P, Thessén Hedreul M, Flytzani S, Beyeen AD, Gillett A, Krivosija N, Öckinger J, Ferguson-Smith AC, Jagodic M.

PLoS Genet. 2014 Mar 27;10(3):e1004265. doi: 10.1371/journal.pgen.1004265. eCollection 2014 Mar.

14.

Natural polymorphisms in Tap2 influence negative selection and CD4∶CD8 lineage commitment in the rat.

Tuncel J, Haag S, Yau AC, Norin U, Baud A, Lönnblom E, Maratou K, Ytterberg AJ, Ekman D, Thordardottir S, Johannesson M, Gillett A; EURATRANS Consortium, Stridh P, Jagodic M, Olsson T, Fernández-Teruel A, Zubarev RA, Mott R, Aitman TJ, Flint J, Holmdahl R.

PLoS Genet. 2014 Feb 20;10(2):e1004151. doi: 10.1371/journal.pgen.1004151. eCollection 2014 Feb.

15.

Erratum: Genomes and phenomes of a population of outbred rats and its progenitors.

Baud A, Guryev V, Hummel O, Johannesson M; Rat Genome Sequencing and Mapping Consortium, Flint J.

Sci Data. 2014 Jul 8;1:140016. doi: 10.1038/sdata.2014.16. eCollection 2014.

16.

Genomes and phenomes of a population of outbred rats and its progenitors.

Baud A, Guryev V, Hummel O, Johannesson M; Rat Genome Sequencing and Mapping Consortium, Flint J.

Sci Data. 2014 Jun 10;1:140011. doi: 10.1038/sdata.2014.11. eCollection 2014. Erratum in: Sci Data. 2014;1:140016.

17.

A silent exonic SNP in kdm3a affects nucleic acids structure but does not regulate experimental autoimmune encephalomyelitis.

Gillett A, Bergman P, Parsa R, Bremges A, Giegerich R, Jagodic M.

PLoS One. 2013 Dec 3;8(12):e81912. doi: 10.1371/journal.pone.0081912. eCollection 2013.

18.

Stabilization mechanism of γ-Mg₁₇Al₁₂ and β-Mg₂Al₃ complex metallic alloys.

Vrtnik S, Jazbec S, Jagodič M, Korelec A, Hosnar L, Jagličić Z, Jeglič P, Feuerbacher M, Mizutani U, Dolinšek J.

J Phys Condens Matter. 2013 Oct 23;25(42):425703. doi: 10.1088/0953-8984/25/42/425703. Epub 2013 Sep 30.

PMID:
24080784
19.

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC), Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofontos A, Hakonarson H, Halfpenny C, Hall G, Hall P, Hamsten A, Harley J, Harrower T, Hawkins C, Hellenthal G, Hillier C, Hobart J, Hoshi M, Hunt SE, Jagodic M, Jelčić I, Jochim A, Kendall B, Kermode A, Kilpatrick T, Koivisto K, Konidari I, Korn T, Kronsbein H, Langford C, Larsson M, Lathrop M, Lebrun-Frenay C, Lechner-Scott J, Lee MH, Leone MA, Leppä V, Liberatore G, Lie BA, Lill CM, Lindén M, Link J, Luessi F, Lycke J, Macciardi F, Männistö S, Manrique CP, Martin R, Martinelli V, Mason D, Mazibrada G, McCabe C, Mero IL, Mescheriakova J, Moutsianas L, Myhr KM, Nagels G, Nicholas R, Nilsson P, Piehl F, Pirinen M, Price SE, Quach H, Reunanen M, Robberecht W, Robertson NP, Rodegher M, Rog D, Salvetti M, Schnetz-Boutaud NC, Sellebjerg F, Selter RC, Schaefer C, Shaunak S, Shen L, Shields S, Siffrin V, Slee M, Sorensen PS, Sorosina M, Sospedra M, Spurkland A, Strange A, Sundqvist E, Thijs V, Thorpe J, Ticca A, Tienari P, van Duijn C, Visser EM, Vucic S, Westerlind H, Wiley JS, Wilkins A, Wilson JF, Winkelmann J, Zajicek J, Zindler E, Haines JL, Pericak-Vance MA, Ivinson AJ, Stewart G, Hafler D, Hauser SL, Compston A, McVean G, De Jager P, Sawcer SJ, McCauley JL.

Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29.

20.

Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage.

Adzemovic MZ, Zeitelhofer M, Hochmeister S, Gustafsson SA, Jagodic M.

Exp Neurol. 2013 Nov;249:39-48. doi: 10.1016/j.expneurol.2013.08.002. Epub 2013 Aug 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk